Statement supporting European Directive 2010/63/EU on the protection of animals used for scientific purposes
Tuesday, 10 November 2015 11:50
Tuesday, 13 October 2015 08:44
BSG members and others from the CONFIDeNT study group have reported in The Lancet on the results of their HTA-funded double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial of the use of percutaneous tibial nerve stimulation (PTNS) in comparison with sham electrical stimulation in adults with faecal incontinence. They write that "PTNS given for 12 weeks did not confer significant clinical benefit over sham electrical stimulation in the treatment of adults with faecal incontinence. Further studies are warranted to determine its efficacy in the long term, and in patient subgroups (ie, those with urgency)."
Biomedical Catalyst (Round 8) winners announced
Friday, 21 August 2015 14:37
The MRC has announced that 12 new treatments, diagnostics and medical technologies will receive funding from the eighth round of the successful Biomedical Catalyst (BMC) programme jointly run by Innovate UK and the MRC, which contributed £13m of the total £18m in this round.
Two of the 7 MRC-funded projects are in gastroenterology.
Targeted therapy for inflammatory bowel disease
Crohn's disease is a chronic, inflammatory bowel disease, which can cause severe symptoms including abdominal pain, diarrhoea and weight loss, but for which there is currently no cure. Existing therapies are focused on reducing inflammation of the bowel lining and providing temporary relief of symptoms, but researchers at KCL and the NIHR Comprehensive Biomedical Research Centre are searching for a cure. The team are the first in the world to trial a personalised treatment using T cell therapy in patients with the disease with the hope that, if successful, their research could help other debilitating autoimmune disorders.
Spotting bowel cancer sooner with a fluorescent dye
Spraying a fluorescent dye onto the lining of the bowel could help doctors distinguish between normal and cancerous tissue in the bowel. Normal endoscopy to look for bowel cancer can only spot visible, physical changes to the lining of the bowel. Researchers at the University of Oxford will trial the new approach in 50 patients which will coat the bowel in the dye - it will only stick to healthy tissue leaving a 'black spot' where cancerous cells are. They hope that the technique will help spot cancers earlier, when it's more likely that they can be treated successfully.
BSG Trainee Member wins a UEGW 2015 Top Abstract Prize
Monday, 27 July 2015 15:44
BSG Trainee Member Edmund Derbyshire has won 10,000 Euro from UEG for his abstract "Colonoscopic perforations in the English NHS Bowel Cancer Screening Programme (NHSBCSP) - beware diagnostic perforations and the sigmoid colon". This is one of five prizes awarded for the top abstracts each year. Further details of this prize are available on the UEG website. The BSG would like to congratulate Dr Derbyshire on his achievement.
Page 11 of 13